PROTALIX BIOTHERAPEUTICS INC (PLX)
US74365A3095 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 23.63M | 17.10M | 39.00M | 18.30M | 17.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 5.27M | 4.60M | 3.40M | 2.00M | 4.70M | |||
| Inventories | 19.05M | 16.80M | 18.00M | 13.10M | 8.20M | |||
| Other Current Assets | 21.98M | 6.40M | 1.30M | 22.30M | 1.80M | |||
| Total Current Assets | 69.93M | 44.90M | 61.70M | 55.70M | 32.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.88M | 9.60M | 9.90M | 10.40M | 11.00M | |||
| Other Non-Current Assets | 3.62M | 1.30M | 2.10M | 1.80M | 2.00M | |||
| Total Non-Current Assets | 14.50M | 10.90M | 12.00M | 12.20M | 12.90M | |||
| TOTAL ASSETS | 84.43M | 55.80M | 73.70M | 67.90M | 45.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 4.10M | 4.30M | |||
| Current Portion Of LT Debt. | 20.25M | N/A | N/A | 54.40M | N/A | |||
| Accrued Expenses | 12.37M | 11.10M | 15.50M | 13.00M | 10.40M | |||
| Accounts Payable | 4.32M | 5.90M | 7.00M | 7.20M | 6.50M | |||
| Other Current Liabilities | 8.59M | 15.50M | 10.70M | 7.70M | 18.90M | |||
| Total Current Liabilities | 45.53M | 32.40M | 33.20M | 86.50M | 40.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 28.20M | 27.90M | 100.00K | 51.50M | |||
| Other Non-Current Liabilities | 5.33M | 5.80M | 18.60M | 8.40M | 24.10M | |||
| Total Non-Current Liabilities | 5.33M | 34.00M | 46.50M | 8.50M | 75.50M | |||
| TOTAL LIABILITIES | 50.87M | 66.40M | 79.70M | 95.00M | 115.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -381.55M | -389.90M | -374.90M | -347.40M | -340.80M | |||
| Additional Paid In Capital | 415.05M | 379.20M | 368.90M | 320.30M | 270.50M | |||
| Common Shares | 73.00K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 72.95M | 53.80M | 45.60M | 34.80M | 14.80M | |||
| Tangible Book Value per Share | 0.46 | -0.20 | -0.13 | -0.78 | -4.75 | |||
| Total Shareholders' Equity | 33.57M | -10.60M | -6.00M | -27.00M | -70.30M | |||
| TOTAL LIABILITIES AND EQUITY | 84.43M | 55.80M | 73.70M | 67.90M | 45.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -2.66 | -4.65 | -0.16 | -0.79 | |||
| Current Ratio | 1.54 | 1.39 | 1.86 | 0.64 | 0.81 | |||
| Return On Assets (ROA) | 9.84% | -26.76% | -37.42% | -9.60% | -40.26% | |||
| Return On Equity (ROE) | 24.76% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 21.24% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 54.12% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 54.12% | N/A | N/A | N/A | N/A | |||
All data in USD